ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2017 American Transplant Congress

    Post-Liver Transplant (LT) Early Allograft Dysfunction (EAD) Modulates the Effect of Pre-LT Kidney Function on Post-LT Survival.

    H. Wadei, M. Mai, B. Taner, K. Croome, A. Keaveny, L. Mai, D. Lee.

    Transplant, Mayo Clinic, Jackosonville, FL

    The impact of EAD on post-LT renal recovery remains unknown. Aim: To assess the impact of post-LT EAD on renal recovery and post-LT survival. Methods:…
  • 2017 American Transplant Congress

    Blood and Biopsy Genomic Signatures of Acute Rejection in Liver Transplant Recipients.

    J. Levitsky,1 T. Whisenant,2 S. Kurian,2 S. Rao,1 A. Demetris,3 M. Abecassis.1

    1Northwestern, Chicago; 2The Scripps Research Institute, San Diego; 3University of Pittsburgh, Pittsburgh

    Background: Biomarker profiles diagnostic of acute rejection (AR) could enhance the diagnosis and management of liver transplant (LT) recipients. Our aim was to identify diagnostic…
  • 2017 American Transplant Congress

    Serum AFP Greater Than 200 ng/ml as a Predictor for Low Survival in Patients with Hepatocelullar Carcinoma Recurrence in a Brazilian Multicentric Study.

    I. Boin,1 M. Possatto,1 E. Ataide,1 R. Silva,2 R. Silva,2 H. Felicio,2 L. Amado,3 A. Lima,3 T. Seva-Pereira.1

    1Unit of Liver Transplantation, State University of Campinas, Campinas, SP, Brazil; 2Digestive Surgery - Liver Transplantation, Faculty of Medicine- São Jose do Rio Preto, Rio Preto, SP, Brazil; 3Digestive Surgery - Liver Transplantation, Faculty of Medicine, Federal University of Minas Gerais, Minas Gerais, Brazil

    Introduction: Liver transplantation (LT) is the only potential curative treatment for hepatocellular carcinoma (HCC) with recurrence (HCC-R) diagnosed in 16%. Aim: The objective of this…
  • 2017 American Transplant Congress

    High-Dose Acyclovir for Cytomegalovirus Prevention in Seropositive Solid Organ Transplant Recipients.

    J. Fose,1 E. McCreary,1 M. Jorgenson,1 M. Lucey,2 J. Smith.2

    1Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI; 2Medicine, University of Wisconsin Hospital and Clinics, Madison, WI

    Purpose: Evaluate the incidence of cytomegalovirus (CMV) infection in seropositive (R+) solid organ transplant recipients (SOT) receiving high-dose acyclovir (HD-A, 800 mg QID) prophylaxis.Methods: Retrospective…
  • 2017 American Transplant Congress

    Readmissions After Liver Transplantation–They May Be Predictable, but Are They Inevitable?

    B. O'Brien, C. Mardis, A. Mardis, J. Fleming, H. Meadows, N. Patel, N. Pilch, C. Perez, M. Sell, A. Rogers, I. Lee, J. McGillicuddy, K. Chavin, D. DuBay, D. Taber.

    Dept of Tx Surgery, Tx ICCE, Dept of Pharmacy, MUSC, Charleston, SC

    Purpose: Published studies suggest that approximately 40% of OLTx recipients are readmitted within 30 days. The aim of this study is to analyze the risk…
  • 2017 American Transplant Congress

    Incidence and Outcomes of Re-Explorations in Living Donor Liver Transplantation.

    V. Varma, S. Sable, S. Kapoor, A. Chauhan, V. Kumaran.

    Hepato-Biliary-Pancreatic Surgery and Liver Transplantation, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra, India

    Introduction: Re-exploration in Living Donor Liver Transplantation(LDLT) is required in patients for various causes, bleeding being the commonest cause. The outcome of these patients is…
  • 2017 American Transplant Congress

    Long-Term Pediatric Live-Donor Liver Transplantation Survivors: Patient and Allograft Outcomes.

    N. Celik,1 A. Ganoza,1 G. Bond,1 K. Soltys,1 R. Sindhi,1 P. McKiernan,3 A. Humar,2 G. Mazariegos.1

    1Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA; 2Thomas E. Starzl Transplantation Institute, Pittsburgh, PA; 3Division of Pediatric Gastroenterology, Pittsburgh, PA

    Aim: To determine the patient and allograft outcomes at 5 years after pediatric live-donor liver transplantation (LDLT).Methods: Children with a minimum of 5-year survival post-transplantation…
  • 2017 American Transplant Congress

    National Trends in Utilization of Donation After Cardiac Death Donor Livers for Transplantation.

    S. Kubal,1 R. Mangus,1 B. Ekser,1 R. Amos,2 J. Fridell.1

    1Department of Surgery, Division of Transplantation, Indiana University School of Medicine, Indianapolis, IN; 2Indiana Donor Network, Indianapolis, IN

    Background: Optimizing utilization of donation after cardiac death (DCD) livers is imperative to address organ shortage. Understanding factors that contribute to DCD liver discards is…
  • 2017 American Transplant Congress

    Decellularized Rat Liver Scaffolds Support Survival and Metabolic Function of Multilineage Allogenic Cells.

    W. Hassanein, A. Werdesheim, A. Cimeno, B. Buckingham, A. Khalifeh, M. Uluer, J. Harrison, D. Parsell, C. Drachenberg, R. Barth, J. LaMattina.

    University of Maryland School of Medcine, Baltimore, MD

    Background:Organ bioengineering has the potential to completely eliminate the donor organ shortage. Here, we examine the feasibility of a decellularized liver construct to support the…
  • 2017 American Transplant Congress

    Subclinical Histologic Findings Are Observed in 25% of Stable Adult Liver Transplant Recipients (ALTRs) Screened for Immunosuppression Withdrawal (ISW): OPTIMAL (NCT02533180).

    S. Chandran,1 M. Abecassis,2 J. Levitsky,2 S. Feng,3 A. Humar,4 J. Emond,5 G. Klintmalm,6 A. Demetris,4 K. Much,7 L. Sun,1 A. Priore,8 D. Ikle,7 N. Bridges,8 M. DesMarais,1 B. Burrell,9 J. Markmann.10

    1ITN, San Francisco; 2Northwestern, Chicago; 3UCSF, San Francisco; 4UPMC, Pittsburgh; 5Columbia, New York; 6Baylor, Dallas; 7Rho, Chapel Hill; 8NIAID/NIH, Bethesda; 9ITN, Bethesda; 10MGH, Boston

    OPTIMAL is a 6-center ISW study in non-autoimmune, non-HCV ALTRs ≥3 yrs post-transplant (tx). Studies have shown a correlation between portal inflammation associated with tissue…
  • « Previous Page
  • 1
  • …
  • 129
  • 130
  • 131
  • 132
  • 133
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences